Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV)

Latest Posts

  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Nirsevimab estimated at 64% to 74% effective against poor RSV outcomes in infants​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Reports describe good maternal RSV vaccine, drug uptake in their first season​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
UK study finds 2% of primary care antibiotic prescriptions were for RSV—a viral illness​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
RSV vaccine prompts robust immune response in older recipients over 2 seasons​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
US flu activity climbs, with more deaths in kids​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
VA study shows COVID more severe than RSV, flu​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
US flu markers show more rises as COVID levels decline​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Real-world study: RSV vaccine 78% to 80% effective against infection, severe illness in older US veterans​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
US flu activity still high, with 11 new deaths in kids​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
US respiratory disease markers remain high for flu, COVID, RSV​
Load More
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
RSV options: Most pregnant women, parents prefer the maternal RSV vaccine over the infant antibody shot​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Study details full range of what respiratory virus infections look like in young kids​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Asthma, chronic kidney disease and other high-risk conditions increase the risk for severe RSV illness​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Point-of-care respiratory virus testing in nursing homes could prevent hospital transfers​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Getting the RSV vaccine during pregnancy is a game-changer for infant hospitalizations​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
CIDRAP Op-Ed: RSV—the middle child of respiratory season who deserves more attention​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Nirsevimab monoclonal antibody for RSV well tolerated in infants, study suggests​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Only 6 symptoms, conditions appear unique to long COVID, suggesting overlap with other post-viral infections​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
RSV tied to high complication, death rates in hospitalized older adults​
  • Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS
Quick takes: Re-emergent COVID strain, extended US RSV season, typhus in California​